Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Med Chem. 2009 Aug 13;52(15):4694-715. doi: 10.1021/jm900259h.

Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.

Author information

  • 1deCODE biostructures, Inc., 7869 NE Day Road West, Bainbridge Island, Washington 98110, USA.

Erratum in

  • J Med Chem. 2010 Mar 11;53(5):2330-1.

Abstract

We describe a novel fragment library termed fragments of life (FOL) for structure-based drug discovery. The FOL library includes natural small molecules of life, derivatives thereof, and biaryl protein architecture mimetics. The choice of fragments facilitates the interrogation of protein active sites, allosteric binding sites, and protein-protein interaction surfaces for fragment binding. We screened the FOL library against leukotriene A4 hydrolase (LTA4H) by X-ray crystallography. A diverse set of fragments including derivatives of resveratrol, nicotinamide, and indole were identified as efficient ligands for LTA4H. These fragments were elaborated in a small number of synthetic cycles into potent inhibitors of LTA4H representing multiple novel chemotypes for modulating leukotriene biosynthesis. Analysis of the fragment-bound structures also showed that the fragments comprehensively recapitulated key chemical features and binding modes of several reported LTA4H inhibitors.

PMID:
19618939
[PubMed - indexed for MEDLINE]
PMCID:
PMC2722745
Free PMC Article

Images from this publication.See all images (9)Free text

Figure 1
Figure 2
Figure 3
Scheme 1
Figure 4
Figure 5
Scheme 2
Figure 6
Scheme 3
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American Chemical Society Icon for PubMed Central
    Loading ...
    Write to the Help Desk